Literature DB >> 18552506

Vascular effects of FGF-2 and VEGF-B in rabbits with bilateral hind limb ischemia.

Rafif Wafai1, Elizabeth M Tudor, James A Angus, Christine E Wright.   

Abstract

AIMS: To assess fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor-B (VEGF-B) effects on flow reserve and morphological adaptation in the rabbit ischemic hind limb.
METHODS: Following bilateral femoral artery ligation, calf blood pressure (C(BP)), flow reserve, collateral artery numbers and capillary numbers were assessed. Treatment consisted of rabbit serum albumin (RSA), FGF-2, VEGF-B or FGF-2 + VEGF-B.
RESULTS: Ligation decreased C(BP); on day 14, a 48% deficit remained in the RSA group compared with a deficit of only 22% in FGF-2 and VEGF-B groups. On day 3, flow reserve was attenuated 60%, but recovered by day 14 (with no treatment effects). Collateral artery numbers increased with RSA (+28%), FGF-2 (+53%), VEGF-B (+47%) and FGF-2 + VEGF-B (+59%). Rectus femoris muscle total capillary profiles and fibers per cross-section were alike across groups. Tibialis anterior muscle cross-sectional area was lower with ligation and total capillary number was less in RSA and FGF-2 groups, providing evidence for angiogenesis with VEGF-B. Capillary/muscle fiber ratio was similar in each group.
CONCLUSIONS: FGF-2 and VEGF-B enhanced lower limb perfusion as indicated by improved C(BP) and combined treatment increased collateral artery number. Flow reserve recovery was not enhanced by cytokine treatment. VEGF-B, but not FGF-2, caused angiogenesis in the tibialis anterior muscle. Overall, VEGF-B may have advantages over FGF-2 in this setting; however, their combination may further improve arteriogenesis. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18552506     DOI: 10.1159/000139132

Source DB:  PubMed          Journal:  J Vasc Res        ISSN: 1018-1172            Impact factor:   1.934


  11 in total

1.  VEGF-B is dispensable for blood vessel growth but critical for their survival, and VEGF-B targeting inhibits pathological angiogenesis.

Authors:  Fan Zhang; Zhongshu Tang; Xu Hou; Johan Lennartsson; Yang Li; Alexander W Koch; Pierre Scotney; Chunsik Lee; Pachiappan Arjunan; Lijin Dong; Anil Kumar; Tuomas T Rissanen; Bin Wang; Nobuo Nagai; Pierre Fons; Robert Fariss; Yongqing Zhang; Eric Wawrousek; Ginger Tansey; James Raber; Guo-Hua Fong; Hao Ding; David A Greenberg; Kevin G Becker; Jean-Marc Herbert; Andrew Nash; Seppo Yla-Herttuala; Yihai Cao; Ryan J Watts; Xuri Li
Journal:  Proc Natl Acad Sci U S A       Date:  2009-04-06       Impact factor: 11.205

2.  Increased perfusion and angiogenesis in a hindlimb ischemia model with plasmid FGF-2 delivered by noninvasive electroporation.

Authors:  B Ferraro; Y L Cruz; M Baldwin; D Coppola; R Heller
Journal:  Gene Ther       Date:  2010-04-15       Impact factor: 5.250

Review 3.  VEGF therapy for the kidney: emerging strategies.

Authors:  Erika Guise; Alejandro R Chade
Journal:  Am J Physiol Renal Physiol       Date:  2018-02-14

Review 4.  Angiogenic cytokines in renovascular disease: do they have potential for therapeutic use?

Authors:  Alejandro R Chade; Nicholas Stewart
Journal:  J Am Soc Hypertens       Date:  2013-02-19

Review 5.  VEGF-B: a survival, or an angiogenic factor?

Authors:  Xuri Li; Chunsik Lee; Zhongshu Tang; Fan Zhang; Pachiappan Arjunan; Yang Li; Xu Hou; Anil Kumar; Lijin Dong
Journal:  Cell Adh Migr       Date:  2009-10-03       Impact factor: 3.405

6.  VEGF: Potential therapy for renal regeneration.

Authors:  Alejandro R Chade
Journal:  F1000 Med Rep       Date:  2012-01-03

7.  Galectin-2 induces a proinflammatory, anti-arteriogenic phenotype in monocytes and macrophages.

Authors:  Cansu Yıldırım; Daphne Y S Vogel; Maurits R Hollander; Josefien M Baggen; Ruud D Fontijn; Sylvia Nieuwenhuis; Anouk Haverkamp; Margreet R de Vries; Paul H A Quax; Juan J Garcia-Vallejo; Anja M van der Laan; Christine D Dijkstra; Tineke C T M van der Pouw Kraan; Niels van Royen; Anton J G Horrevoets
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

8.  Astragalosides promote angiogenesis via vascular endothelial growth factor and basic fibroblast growth factor in a rat model of myocardial infarction.

Authors:  Jun-Min Yu; Xiao-Bo Zhang; Wen Jiang; Hui-Dong Wang; Yi-Na Zhang
Journal:  Mol Med Rep       Date:  2015-09-09       Impact factor: 2.952

9.  VEGF-B Levels in the Vitreous of Diabetic and Non-Diabetic Patients with Ocular Diseases and Its Correlation with Structural Parameters.

Authors:  Joana Mesquita; João Paulo Castro de Sousa; Sara Vaz-Pereira; Arminda Neves; Paulo Tavares-Ratado; Fátima M Santos; Luís A Passarinha; Cândida T Tomaz
Journal:  Med Sci (Basel)       Date:  2017-08-09

10.  Neovasculature can be induced by patching an arterial graft into a vein: A novel in vivo model of spontaneous arteriovenous fistula formation.

Authors:  Yukinobu Ito; Makoto Yoshida; Daichi Maeda; Masato Takahashi; Hiroshi Nanjo; Hirotake Masuda; Akiteru Goto
Journal:  Sci Rep       Date:  2018-02-16       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.